DP
AGN

Dearborn Partners’s Allergan plc AGN Stock Holding History

Dearborn Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-831
Closed -$202K – 173
2017
Q2 		$202K Buy
+831
New +$195K 0.01% 167
2016
Q4 		– Sell
-1,609
Closed -$371K – 192
2016
Q3 		$371K Sell
1,609
-415
-21% -$101K 0.03% 141
2016
Q2 		$468K Buy
2,024
+38
+2% +$8.76K 0.04% 123
2016
Q1 		$532K Hold
1,986
– – 0.05% 113
2015
Q4 		$621K Buy
1,986
+61
+3% +$18.2K 0.06% 141
2015
Q3 		$523K Sell
1,925
-427
-18% -$131K 0.05% 152
2015
Q2 		$714K Sell
2,352
-1,795
-43% -$535K 0.07% 143
2015
Q1 		$1.23M Buy
+4,147
New +$1.18M 0.11% 152

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Dearborn Partners's AGN Position: Q3 2017 in Review

Dearborn Partners sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 831 shares — an estimated $202K sold.

Dearborn Partners first reported a position in AGN in Q1 2015 and held it in 8 quarters. The position peaked at $1.23M in Q1 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Dearborn Partners reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Dearborn Partners sold 831 Allergan plc shares in Q3 2017, an estimated $202K.
  • Dearborn Partners first reported a position in Allergan plc in Q1 2015 and held it in 8 quarters.
  • Dearborn Partners's Allergan plc position peaked at $1.23M in Q1 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Dearborn Partners's 13F filing for Q3 2017, filed 13 Nov 2017.